Birchview Capital

Birchview Capital as of March 31, 2016

Portfolio Holdings for Birchview Capital

Birchview Capital holds 40 positions in its portfolio as reported in the March 2016 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Celgene Corporation 55.6 $78M 779k 100.09
Accelr8 Technology 22.3 $31M 2.2M 14.37
Vermillion 2.9 $4.0M 2.7M 1.47
Metabolix 2.8 $3.9M 2.3M 1.71
EQT Corporation (EQT) 2.0 $2.8M 42k 67.26
Biolase Technology 1.2 $1.7M 1.3M 1.31
Contrafect 1.1 $1.6M 475k 3.40
Masimo Corporation (MASI) 1.1 $1.5M 37k 41.83
Collegium Pharmaceutical Inc Common Stock Usd (COLL) 1.0 $1.4M 77k 18.15
Hansen Medical 1.0 $1.4M 528k 2.61
Neurocrine Biosciences (NBIX) 0.7 $997k 25k 39.56
Medivation 0.6 $863k 19k 46.00
Merck & Co (MRK) 0.6 $794k 15k 52.93
Encana Corp 0.6 $806k 132k 6.09
Oncomed Pharmaceuticals 0.5 $715k 71k 10.11
Quidel Corporation 0.5 $673k 39k 17.27
Oxford Immunotec Global 0.4 $558k 56k 9.91
Accuray Incorporated (ARAY) 0.4 $551k 95k 5.78
Quotient 0.4 $512k 58k 8.80
Wright Medical 0.4 $498k 30k 16.60
Cabot Oil & Gas Corporation (CTRA) 0.3 $477k 21k 22.71
Sientra 0.3 $433k 63k 6.84
Pioneer Natural Resources (PXD) 0.3 $422k 3.0k 140.67
NxStage Medical 0.3 $423k 28k 15.00
Corcept Therapeutics Incorporated (CORT) 0.3 $374k 80k 4.68
Merrimack Pharmaceuticals In 0.3 $368k 44k 8.36
Advaxis 0.2 $321k 36k 9.02
Kura Oncology (KURA) 0.2 $320k 79k 4.04
Celgene Corp right 12/31/2011 0.2 $312k 238k 1.31
Tesaro 0.2 $306k 7.0k 44.03
Genocea Biosciences 0.2 $302k 39k 7.74
Biogen Idec (BIIB) 0.2 $260k 1.0k 260.00
Pacific Biosciences of California (PACB) 0.2 $230k 27k 8.52
Transition Therapeutics 0.1 $187k 146k 1.28
Raptor Pharmaceutical 0.1 $184k 40k 4.60
Intercept Pharmaceuticals In 0.1 $167k 1.3k 128.46
Xencor (XNCR) 0.1 $165k 12k 13.41
Roka Bioscience 0.1 $174k 252k 0.69
Cerus Corporation (CERS) 0.1 $157k 27k 5.92
Coherus Biosciences (CHRS) 0.1 $159k 7.5k 21.20